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ABSTRACT
International Journal of Exercise Science 10(4): 550-559, 2017. Betaine (BT)
supplementation improves selected markers of physical performance, however, the
mechanism(s) by which this change occurs remains largely unknown. Some speculate that BT
may increase circulating nitrate concentrations, improving physical performance by
augmentation of endothelial nitric oxide production. The purpose of this study was to investigate
the effects of acute BT supplementation and exercise on plasma nitrate levels and related
cardiovascular response (CVR). Placebo and BT trials were administered in a cross-over,
randomized, double-blind, and counterbalanced fashion. Ten healthy college-aged volunteers
consumed either a 250 ml placebo (carbohydrate-electrolyte beverage, CHO) or 250 ml CHO + 2.5
g BT. Subjects rested for 45 min, then cycled for 30 min at 60 rpm with a resistance of 2.5% body
weight. Blood was drawn before and 45 min after BT supplementation, and immediately post
exercise to assess plasma nitrate levels. Repeated measures ANOVA across treatments and times
assessed differences in plasma nitrate and CVR variables with an alpha level set at 0.05. No
significant interactions nor differences between groups were found for plasma nitrate levels or
CVR variables with acute BT supplementation. A significant time effect (p < 0.013) for all CVR
variables was found and expected due to the effect of exercise. Acute BT supplementation did not
increase plasma nitrate levels nor alter CVR at rest or during light to moderate cycling.
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INTRODUCTION
There is growing interest in investigating nitrate containing supplements given the promising
health and physical performance findings (16). Nitrate can be recycled to bioactive nitric oxide
(NO) under certain physiological conditions and through the action of NO, modulate skeletal
muscle function, contraction, mitochondrial respiration and biogenesis, and blood flow (16).
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Betaine (BT) is a naturally occurring compound found in many foods including beets and
spinach, which are rich in nitrate (32, 40).
BT supplementation improves athletic performance by enhancing metabolism when consumed
with a carbohydrate-electrolyte fluid replacement drink. For example, our laboratory (31) and
others (4, 13, 22) showed BT supplementation improved select physical performance measures,
likely due to its ability to donate methyl groups thereby upregulating creatine synthesis in
skeletal muscle (3, 7). This mechanism, however, was recently questioned (8). Alternatively, it
may be that BT’s ergogenicity is related to its ability to upregulate gene expression of NO
synthase resulting in increased NO availability (15). It may also be that BT supplementation
increases circulating nitrate concentrations, resulting in improved performance through the
nitrate-NO pathway.
Two studies evaluated whether BT supplementation affected the nitrate-NO pathway at rest.
BT supplementation increased resting plasma NO in older adults from 28.8 ± 3.4 µmol.L-1 to
82.3 ± 13.2 µmol.L-1 after 6 g.d-1 for one week (14). More recently, it was shown that resting
concentrations of nitrite and nitrate, precursors to NO (18), were unaffected by acute or
chronic BT supplementation (1.25 – 6 g for up to 14 days) in young exercise trained men (2).
The discordance among studies examining the effects of BT supplementation at rest on nitrate
and NO necessitates additional research. Furthermore, BT is sourced from nitrate rich foods
and remains a common ingredient in many pre-exercise supplements. Although BT may or
may not affect the nitrate-NO pathway at rest, it remains unknown whether the combination
of exercise plus BT consumption may have a synergistic effect on the nitrate-NO pathway.
It is possible that exercise and BT may work synergistically to elevate nitrate levels and
subsequently NO. Accordingly, BT supplementation could enhance exercise performance
(e.g., greater hyperemia in working muscles), recovery (e.g., anti-inflammatory), and
cardiovascular health (e.g., inhibition of platelet aggregation and adhesion) through the
association of nitrate with NO (5, 6, 9, 16, 19, 39). Considering the emerging interest in nitrate
as an ergogenic aid and the dissonance of previous studies evaluating the effect of BT
supplementation at rest on measures of nitrate, further investigation is needed. Therefore, the
aim of this investigation was to determine if acute BT supplementation combined with
moderate intensity exercise affects nitrate levels and cardiovascular responses to exercise.
METHODS
Participants
Ten healthy college aged males volunteered to participate in the study. All subjects were
recreationally active (a population likely to use such a supplement), participating in light to
moderate exercise ≥3 days per week and not engaged in a collegiate sport or periodized
endurance or resistance training program. Subjects were excluded if they reported high blood
pressure, history of diabetes, renal disease, current orthopedic injuries that would prevent
cycling, allergies, illness or any other medical reason that may endanger them or affect the
quality of the study. Subjects who chose to participate were made aware of risks, benefits, and
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protocols of the study before providing informed consent. Subjects did not consume any
caffeine, alcohol, or any other drugs within 24 h of testing sessions and maintained current
physical activity and dietary habits throughout the course of the study. Additionally, subjects
discontinued any nitrate/NO boosting supplements at least 14 d prior to data collection and
were not permitted concomitant supplementation during this study. The methods of this
study were approved by the college Human Subjects Review Board.
Protocol
This study utilized a placebo controlled, double-blind, repeated measures design. To limit the
influence of diet and relative cycling workload on BT and NO levels, a crossover design.
Placebo and BT (BetaPower™ Danisco A/S, White Plains, NY) trials were administered in a
partially randomized, counterbalanced fashion to reduce order effects. Subjects completed a
12-hour fast prior to testing. Subjects consumed either a 250 ml placebo (carbohydrateelectrolyte beverage, CHO) or a 250 ml carbohydrate-electrolyte beverage with 2.5g BT (CHO
+ BT). To ensure beverage anonymity, all subjects received uniform opaque sport drink
bottles with cap ties broken. Monark (Series 818e, Varberg, Sweden) cycle ergometers were
calibrated each day prior to data collection by one of two researchers to ensure accurate
resistance levels.
All data collection sessions were time-matched between visits and completed between the
hours of 8:00 and 11:00 AM in a temperature controlled laboratory (72º F). Upon subject
arrival, 3.5 ml of blood was drawn to assess baseline plasma nitrate levels (-45 min). Subjects
then consumed either the CHO or CHO + BT beverage and sat for 45 min. Based upon human
digestion pharmacokinetics of BT, 45 min allows BT to reach peak levels in the plasma (0.65 1.3 hrs post-digestion; Schwahn, Hafner, Hohlfeld, Balkenhol, Laryea, et al., 2003). During this
time, subjects sat quietly and were free to read, study, or use a computer. After this 45 min
period, another resting blood sample was taken (0 min). On a cycle ergometer with seat height
adjusted to 10-15° knee flexion, subjects completed a 30 min cycling bout at 60 rpm with
resistance set at 2.5% body weight (kg). The calculated workload was analogous to light to
moderate intensity exercise. Blood was drawn immediately after the 30 min cycling bout and
the subjects then cooled down for 5 min against light resistance. Subjects completed a second
trial in the alternate condition after waiting 6 to 8 d to allow for adequate BT wash out.
To ensure hydration, subjects drank 12 oz of water prior to sleeping the night before and again
on the morning of data collection. Upon subject arrival, euhydration (Usg ≤ 1.025 µG) was
verified using a digital refractometer (KS-0050; Kernco Instruments, El Paso, TX). The subject
was then fitted with a Polar HR monitor (Model S610i; Polar Electro, Kemplele, Finland), and
HR data were measured during rest (-45, -15, and 0 min) and cycling (15 and 30 min). In
addition, blood pressure data were collected at the same time intervals as HR data using
auscultation and sphygmomanometer.
Venous blood from an antecubital vein was drawn at rest (-45 min, 0 min) and immediately
following cycling (30 min). Blood was collected in citrate containing vials and immediately
centrifuged at 3500 rpm for 10 min at 4º C. Plasma was collected, aliquoted and stored at -80º
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C until analysis. Due to the extremely short half-life of NO and the high degree of
measurement variability, nitrate and/or nitrite concentrations are widely accepted surrogate
markers of NO (18, 23). Therefore, the concentration of inorganic nitrate, a stable end product
of NO oxidation, was assayed by a colorimetric method using the Greiss method in a total NO
Nitrate/Nitrite Assay Kit (Assay Designs Inc., Ann Arbor, MI). The mean minimum
detectable dose for this assay kit was 0.625 µmol.L-1. Samples were ultra-filtrated with 10,000
MWCO filter. All samples were run in duplicate with the average value reported (mean intraassay coefficient of variance = 3.9%).
Statistical Analysis
A 2 x 3 repeated measures ANOVA across treatments (CHO + BT and CHO) and times (-45, 0
and 30 min) assessed differences in plasma nitrate. A 2 x 5 repeated measures ANOVA across
treatments and times (-45, -15, 0, 15 and 30 min) assessed differences in cardiovascular
response variables (CVR; SBP, DBP, MAP and HR). Significant results were further analyzed
using pairwise comparisons with Bonferroni adjustments to control alpha inflation and
minimize the chance of Type 1 error. When sphericity was violated, a Greenhouse-Geisser
analysis was performed. Effect sizes (Cohen’s d) were calculated to assess the magnitude of
difference in nitrate levels between groups. All statistics were performed on PASW (v. 17.0)
with an alpha set at 0.05.
RESULTS
Means ± SD for pertinent anthropometric data were in the expected range (height = 170.0 ±
12.4 cm, weight = 78.7 ± 11.0 kg, and age = 20.2 ± 3.6 y). Relative BT dosage averaged 0.03
g·kg-1 ranging from 0.02-0.04 g·kg-1.
No significant interactions (p = 0.23) nor differences between groups (p = 0.31) or time (p =
0.12) were noted for plasma nitrate levels. Examining descriptive data (means ± SD) in Table
1, nitrate was lowest 45 min after BT supplementation. Nitrate also returned to pre-BT
supplementation levels after 30 min of exercise. Effect sizes at -45 min, 0 min, and 30 min were
0.249, -0.075, and 0.742, respectively.
No significant interactions (HR, p = 0.74; MAP, p = 0.68; SBP, p = 0.80; DBP, p = 0.46) nor
differences between groups (HR, p = 0.40; MAP, p = 0.47; SBP, p = 0.87; DBP, p = 0.32) were
noted for any CVR. There was, however, a significant main effect for time (p ≤ 0.013) on CVR
variables (Figure 1) which was expected due to the 30 min resisted cycling bout.
Table 1. Plasma nitrate levels pre- and post-exercise.
Time (min)
Group
Nitrate (µmol·L-1)
Average (µmol·L-1)
-45
Control
55.1 ± 14.0
53.5 ± 12.8
Betaine
51.9 ± 11.6
0
Control
46.3 ± 11.7
46.8 ± 12.0
Betaine
47.2 ± 12.2
30#
Control
60.8 ± 21.1
54.5 ± 16.8
Betaine
48.2 ± 11.5*
Note. Values are mean ± SD, * n = 10 except this data point where n = 9, # = post-exercise
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Figure 1. Cardiovascular response to BT supplementation at rest and during aerobic exercise. *Significantly
different from rest times (P ≤ 0.013), **Significantly less than -15 min (P ≤ 0.013), †Significantly greater than 15 min
(P ≤ 0.013).

DISCUSSION
The purpose of this study was to investigate the effects of acute BT supplementation and
moderate intensity exercise on plasma nitrate levels. The present study found that the
manufacturer’s recommended BT dose of 2.5 g did not significantly increase plasma nitrate
levels at rest in young fit males, supporting observations from Bloomer et al. (2) but not Iqbal
et al. (14). The conflicting results are most likely due to some combination of the following
factors: amount of BT titration (a function of supplementation dosage), subject population,
and/or time. Upon ingestion, BT is metabolized and stored in the liver and kidneys with
excess BT circulating in the blood (3, 10). With chronic or mega doses, as seen in Iqbal et al.,
BT may overcome the effect of titration and reach the target tissue (smooth muscle
vasculature) enabling upregulation of NO eliciting vasodilation (25) and CVR effects, at least
in older individuals. Again, in the present study BT did not affect resting plasma nitrate
concentrations in young fit males.
Differences across age in the ability to generate NO and the consequential blood flow
implications are documented (12, 24). This relationship may explain the divergent results
regarding BT supplementation, NO levels, and age. In short, older individuals with lower
basal nitrate and nitrite concentrations may respond more favorably to BT supplementation
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than a young population (2). However, Konstantinova et al. (21) observed higher BT levels for
older compared to younger subjects confounding this theory. Regardless, it does not appear
that BT ingestion improves resting nitrate concentrations in young males. Although NO was
not directly measured in this study, it appears that additional research is required to assess the
notions of Iqbal et al. (14) and Jallel-Messadek (15).
Moderate intensity exercise was selected because Goto et al. (11) compared the effects of
training at three exercise intensities for 30 min in healthy young men and found moderate
intensity (50% VO2max) training enhanced endothelium-dependent vasodilation while low
(25% VO2max) and high (75% VO2max) intensities did not. The added oxidative stress
associated with high intensity training may reduce NO bioavailability, diminishing any
vascular effect seen as a result of NO production (25). Additionally, low intensity exercise
may not provide a vasodilatory stimulus strong enough to reach a threshold to promote NO
release and affect CVRs. Despite selecting an exercise intensity likely to affect the nitrate-NO
pathway, plasma nitrate did not increase after the exercise protocol suggesting that BT
supplementation combined with moderate intensity exercise has no synergistic affect
immediately post-exercise. Although plasma nitrate was not different between groups at any
time point, the large effect size (d = 0.742) at 30 min suggests CHO + exercise alone has a
greater effect on plasma nitrate levels than CHO+BT. However, the standard deviation in the
control group at 30 min was twice that of all other measures suggesting this increased plasma
nitrate level was an artifact of the assay or biological variation within our sample population
and likely not indicative of any effect of CHO or exercise on plasma nitrate levels.
If BT increases nitrate concentration subsequently enhancing NO production, an obligatory
vasodilation induced effect on CVRs would be observed. However, we observed BT
supplementation in combination with moderate intensity exercise did not impact CVR
responses to exercise. This finding is mirrored by previous investigations showing no effect of
BT ingestion on HR (1, 28) and blood pressure (33). Similar to the results of this study, Schwab
et al. (33) found no significant differences in resting SBP and DBP between a control and BT
group after a 12 week hypoenergetic diet in 42 obese subjects. Conversely, Konstantinova et
al. (21) demonstrated BT concentration in plasma is inversely related to components of
metabolic syndrome. Specifically, SBP and DBP were identified as having an inverse
relationship when BT is consumed habitually (-0.73, 95% CI: [-1.03, -0.43] and -0.86, 95% CI: [1.13, -0.59], P < 0.0001, respectively). However, the impact of the small yet statistically
significant improvements in SBP and DBP resulting from BT supplementation may not be
clinically relevant.
The presented data should be analyzed within the limitations of our work. NO was not
directly measured in this study due to its extremely short half-life (ranging from milliseconds
to <1 s in circulating blood (18, 22). Typically, NO, in a bidirectional biochemical pathway, is
quickly oxidized to the stable end products nitrite and nitrate, which are then typically
measured. Similar to previous research, we only evaluated nitrate levels (36) which is the
primary NO oxidation metabolite. According to Lundberg and Weitzberg (23), basal plasma
nitrite levels are usually in the range of 0.1-0.5 µmol.L-1, as a consequence the combination of
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nitrite and nitrate measures are almost identical to nitrate levels. However, other research has
shown significant increases in nitrate after a maximal effort test in chronic fatigue syndrome
subjects (37). The effects of acute BT supplementation on nitrate or NO concentrations in other
tissues (e.g., muscle) or exhaled NO concentrations were not determined in this study. BT
supplementation may increase nitrate or NO levels when assessed using these other methods.
The large variance between subject plasma variables (Table 1) diminished the ability to detect
statistical significance. Although our sample size was similar to other ergogenic aid/exercise
performance cross-over studies, we contend that increasing power (via increasing sample size)
would be futile as our main outcome variable was far from significant (p = 0.23). Further, the
percent change scores were extremely small and in some cases negative. To achieve statistical
power, a post-hoc power analysis was performed and revealed up to 1388 additional subjects
would be required to find significant differences between groups in plasma nitrate
concentrations suggesting the risk of Type 2 error was negligible.
We measured plasma nitrate immediately after the cycling bout instead of during exercise. It
is difficult to ascertain whether this methodological factor significantly affected measures of
nitrate and theoretically endothelial derived NO. Exercise intensity and duration is correlated
with NO production during exercise, however, studies measuring NO post-exercise have
shown both significant (29) and non-significant (27, 36) results. Given the variability and
difficulty of directly measuring NO and the half-life of its metabolites, perhaps concomitant
venous sampling using a catheter would be prudent. Finally, local (quadriceps muscle)
increases in NO metabolites may not be sufficient to overcome the diluting effect when
circulating throughout the body to be detected at peripheral (antecubital space) sampling sites,
a theory originally purported by St. Croix et al (36).
Within the limitations of this study, an acute dose (2.5 g) of BT had no CVR effect at rest or
during 30 min of moderate cycling. Additionally, acute BT supplementation did not increase
resting or post-exercise plasma nitrate levels. While other ergogenic effects may occur with
acute BT supplementation, benefits sought with elevated nitrate or NO production does not
appear to occur in young individuals (our data; 2) but may occur in other populations such as
older individuals (14, 15), females or untrained populations. Manipulation of acute program
variables such as resistance and endurance training modes, intensities, and durations may
exhibit differential effects on nitrate and NO production in combination with chronic BT
supplementation and merits future investigation. Chronic BT supplementation may produce
different NO levels during exercise and should also be explored.
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